Építés alatt – nem éles oldal
Belépés

Krónikus vesebetegség trials, also abroad

942 open Krónikus vesebetegség trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok223
Kína122
Franciaország85
Spanyolország44
Németország43
All other countries

The same trial often runs in several countries

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy has 1 site in Hongkong and runs in 36 countries. If a site near you is full, another one may still take people.

See A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy in all 36 countries
Építés alatt, nem éles – Krónikus vesebetegség: vizsgálatok itt: Hongkong – Frontlight Research